HEADER HYDROLASE 04-DEC-01 1GQS TITLE ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH NAP COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACHE; COMPND 5 EC: 3.1.1.7 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787; SOURCE 5 VARIANT: G2 FORM; SOURCE 6 ORGAN: ELECTRIC ORGAN; SOURCE 7 TISSUE: ELECTROPLAQUE KEYWDS HYDROLASE, NEUROTRANSMITTER CLEAVAGE, ANTI-ALZHEIMER DRUG EXPDTA X-RAY DIFFRACTION AUTHOR P.BAR-ON,C.B.MILLARD,M.HAREL,H.DVIR,A.ENZ,J.L.SUSSMAN,I.SILMAN REVDAT 6 16-OCT-24 1GQS 1 REMARK REVDAT 5 13-DEC-23 1GQS 1 HETSYN REVDAT 4 29-JUL-20 1GQS 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 07-SEP-11 1GQS 1 COMPND REMARK HETSYN FORMUL REVDAT 3 2 1 SITE VERSN REVDAT 2 24-FEB-09 1GQS 1 VERSN REVDAT 1 15-MAR-02 1GQS 0 JRNL AUTH P.BAR-ON,C.B.MILLARD,M.HAREL,H.DVIR,A.ENZ,J.L.SUSSMAN, JRNL AUTH 2 I.SILMAN JRNL TITL KINETIC AND STRUCTURAL STUDIES ON THE INTERACTION OF JRNL TITL 2 CHOLINESTERASES WITH THE ANTI-ALZHEIMER DRUG RIVASTIGMINE JRNL REF BIOCHEMISTRY V. 41 3555 2002 JRNL REFN ISSN 0006-2960 JRNL PMID 11888271 JRNL DOI 10.1021/BI020016X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.L.SUSSMAN,M.HAREL,F.FROLOW,C.OEFNER,A.GOLDMAN,L.TOKER, REMARK 1 AUTH 2 I.SILMAN REMARK 1 TITL ATOMIC STRUCTURE OF ACETYLCHOLINESTERASE FROM TORPEDO REMARK 1 TITL 2 CALIFORNICA: A PROTOTYPIC ACETYLCHOLINE-BINDING PROTEIN REMARK 1 REF SCIENCE V. 253 872 1991 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 1678899 REMARK 1 DOI 10.1126/SCIENCE.1678899 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 20004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1006 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3094 REMARK 3 BIN R VALUE (WORKING SET) : 0.3550 REMARK 3 BIN FREE R VALUE : 0.4240 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 164 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.033 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4245 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 142 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.86000 REMARK 3 B22 (A**2) : 9.86000 REMARK 3 B33 (A**2) : -19.72000 REMARK 3 B12 (A**2) : 8.82000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.66 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.47 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.88 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.620 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.770 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.500 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.970 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 41.50 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GQS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-DEC-01. REMARK 100 THE DEPOSITION ID IS D_1290009071. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20004 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 29.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.64000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1ACE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.80 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.74233 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.48467 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 91.48467 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.74233 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 754 O HOH A 762 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 39 45.70 -68.50 REMARK 500 PHE A 45 -16.40 72.83 REMARK 500 ALA A 60 55.61 -115.32 REMARK 500 SER A 91 140.45 -173.52 REMARK 500 LEU A 95 96.00 -69.20 REMARK 500 SER A 108 84.37 -167.38 REMARK 500 VAL A 129 0.76 -68.15 REMARK 500 SER A 200 -122.97 64.34 REMARK 500 SER A 291 -72.93 -56.67 REMARK 500 GLU A 299 -80.37 -103.73 REMARK 500 ASN A 313 79.51 -68.08 REMARK 500 THR A 317 -158.69 179.91 REMARK 500 ASP A 326 70.18 -113.61 REMARK 500 VAL A 360 67.69 -118.11 REMARK 500 ASP A 380 42.56 -171.78 REMARK 500 ASP A 381 -0.91 -57.23 REMARK 500 VAL A 400 -63.16 -132.56 REMARK 500 THR A 412 -33.35 -38.96 REMARK 500 PHE A 414 -16.89 -140.87 REMARK 500 GLU A 455 -8.17 -54.12 REMARK 500 SER A 490 112.23 24.30 REMARK 500 ARG A 515 77.14 46.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 842 DISTANCE = 6.49 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ACJ RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH TACRINE REMARK 900 RELATED ID: 1ACL RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH DECAMETHONIUM REMARK 900 RELATED ID: 1AMN RELATED DB: PDB REMARK 900 TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N, REMARK 900 N-TRIMETHYLAMMONIO) TRIFLUOROACETOPHENONE REMARK 900 RELATED ID: 1AX9 RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, LAUE DATA REMARK 900 RELATED ID: 1CFJ RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O- ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) REMARK 900 RELATED ID: 1DX6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-GALANTHAMINE REMARK 900 AT 2.3A RESOLUTION REMARK 900 RELATED ID: 1E3Q RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51 REMARK 900 RELATED ID: 1E66 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-HUPRINE X AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1EA5 RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7 ) FROM TORPEDO REMARK 900 CALIFORNICA AT 1.8A RESOLUTION REMARK 900 RELATED ID: 1EEA RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1EVE RELATED DB: PDB REMARK 900 THREE DIMENSIONAL STRUCTURE OF THE ANTI- ALZHEIMER DRUG, E2020 REMARK 900 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1FSS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN- II REMARK 900 RELATED ID: 1GPK RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXE WITH (+)-HUPERZINE A AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1GPN RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT REMARK 900 2.35A RESOLUTION REMARK 900 RELATED ID: 1HBJ RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN TORPEDO CALIFORNICA ACHE REMARK 900 AND A REVERSIBLE INHIBITOR, 4-AMINO-5-FLUORO-2-METHYL-3-( 3- REMARK 900 TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE REMARK 900 RELATED ID: 1OCE RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH MF268 REMARK 900 RELATED ID: 1QID RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 A) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIE RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 B) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIF RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 C) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIG RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 D) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIH RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 E) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QII RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 F) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIJ RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 G) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIK RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 H) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIM RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 I) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QTI RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1SOM RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT REMARK 900 GD (SOMAN). REMARK 900 RELATED ID: 1VOT RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE A REMARK 900 RELATED ID: 1VXO RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1VXR RELATED DB: PDB REMARK 900 O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 2ACE RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 2ACK RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, MONOCHROMATIC DATA REMARK 900 RELATED ID: 2DFP RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF AGED DI-ISOPROPYL- PHOSPHORO-FLUORIDATE (DFP) REMARK 900 BOUND TO ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 3ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (R)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES REMARK 900 RELATED ID: 4ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (S)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES REMARK 900 RELATED ID: 1GQR RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH RIVASTIGMINE DBREF 1GQS A 4 535 UNP P04058 ACES_TORCA 25 556 SEQRES 1 A 532 SER GLU LEU LEU VAL ASN THR LYS SER GLY LYS VAL MET SEQRES 2 A 532 GLY THR ARG VAL PRO VAL LEU SER SER HIS ILE SER ALA SEQRES 3 A 532 PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO VAL GLY ASN SEQRES 4 A 532 MET ARG PHE ARG ARG PRO GLU PRO LYS LYS PRO TRP SER SEQRES 5 A 532 GLY VAL TRP ASN ALA SER THR TYR PRO ASN ASN CYS GLN SEQRES 6 A 532 GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SER GLY SER SEQRES 7 A 532 GLU MET TRP ASN PRO ASN ARG GLU MET SER GLU ASP CYS SEQRES 8 A 532 LEU TYR LEU ASN ILE TRP VAL PRO SER PRO ARG PRO LYS SEQRES 9 A 532 SER THR THR VAL MET VAL TRP ILE TYR GLY GLY GLY PHE SEQRES 10 A 532 TYR SER GLY SER SER THR LEU ASP VAL TYR ASN GLY LYS SEQRES 11 A 532 TYR LEU ALA TYR THR GLU GLU VAL VAL LEU VAL SER LEU SEQRES 12 A 532 SER TYR ARG VAL GLY ALA PHE GLY PHE LEU ALA LEU HIS SEQRES 13 A 532 GLY SER GLN GLU ALA PRO GLY ASN VAL GLY LEU LEU ASP SEQRES 14 A 532 GLN ARG MET ALA LEU GLN TRP VAL HIS ASP ASN ILE GLN SEQRES 15 A 532 PHE PHE GLY GLY ASP PRO LYS THR VAL THR ILE PHE GLY SEQRES 16 A 532 GLU SER ALA GLY GLY ALA SER VAL GLY MET HIS ILE LEU SEQRES 17 A 532 SER PRO GLY SER ARG ASP LEU PHE ARG ARG ALA ILE LEU SEQRES 18 A 532 GLN SER GLY SER PRO ASN CYS PRO TRP ALA SER VAL SER SEQRES 19 A 532 VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU LEU GLY ARG SEQRES 20 A 532 ASN LEU ASN CYS ASN LEU ASN SER ASP GLU GLU LEU ILE SEQRES 21 A 532 HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU LEU ILE ASP SEQRES 22 A 532 VAL GLU TRP ASN VAL LEU PRO PHE ASP SER ILE PHE ARG SEQRES 23 A 532 PHE SER PHE VAL PRO VAL ILE ASP GLY GLU PHE PHE PRO SEQRES 24 A 532 THR SER LEU GLU SER MET LEU ASN SER GLY ASN PHE LYS SEQRES 25 A 532 LYS THR GLN ILE LEU LEU GLY VAL ASN LYS ASP GLU GLY SEQRES 26 A 532 SER PHE PHE LEU LEU TYR GLY ALA PRO GLY PHE SER LYS SEQRES 27 A 532 ASP SER GLU SER LYS ILE SER ARG GLU ASP PHE MET SER SEQRES 28 A 532 GLY VAL LYS LEU SER VAL PRO HIS ALA ASN ASP LEU GLY SEQRES 29 A 532 LEU ASP ALA VAL THR LEU GLN TYR THR ASP TRP MET ASP SEQRES 30 A 532 ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY LEU ASP ASP SEQRES 31 A 532 ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO LEU MET HIS SEQRES 32 A 532 PHE VAL ASN LYS TYR THR LYS PHE GLY ASN GLY THR TYR SEQRES 33 A 532 LEU TYR PHE PHE ASN HIS ARG ALA SER ASN LEU VAL TRP SEQRES 34 A 532 PRO GLU TRP MET GLY VAL ILE HIS GLY TYR GLU ILE GLU SEQRES 35 A 532 PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU LEU ASN TYR SEQRES 36 A 532 THR ALA GLU GLU GLU ALA LEU SER ARG ARG ILE MET HIS SEQRES 37 A 532 TYR TRP ALA THR PHE ALA LYS THR GLY ASN PRO ASN GLU SEQRES 38 A 532 PRO HIS SER GLN GLU SER LYS TRP PRO LEU PHE THR THR SEQRES 39 A 532 LYS GLU GLN LYS PHE ILE ASP LEU ASN THR GLU PRO MET SEQRES 40 A 532 LYS VAL HIS GLN ARG LEU ARG VAL GLN MET CYS VAL PHE SEQRES 41 A 532 TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN ALA THR MODRES 1GQS ASN A 59 ASN GLYCOSYLATION SITE MODRES 1GQS ASN A 416 ASN GLYCOSYLATION SITE HET NAG A 601 14 HET NAG A 602 14 HET SAF A 603 12 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SAF 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 SAF C10 H15 N O FORMUL 5 HOH *142(H2 O) HELIX 1 AA1 VAL A 40 ARG A 44 5 5 HELIX 2 AA2 PHE A 78 MET A 83 1 6 HELIX 3 AA3 LEU A 127 ASN A 131 5 5 HELIX 4 AA4 GLY A 132 GLU A 140 1 9 HELIX 5 AA5 GLY A 151 LEU A 156 1 6 HELIX 6 AA6 ASN A 167 ILE A 184 1 18 HELIX 7 AA7 GLN A 185 PHE A 187 5 3 HELIX 8 AA8 SER A 200 SER A 212 1 13 HELIX 9 AA9 SER A 212 ASP A 217 1 6 HELIX 10 AB1 VAL A 238 LEU A 252 1 15 HELIX 11 AB2 SER A 258 LYS A 269 1 12 HELIX 12 AB3 LYS A 270 GLU A 278 1 9 HELIX 13 AB4 TRP A 279 LEU A 282 5 4 HELIX 14 AB5 SER A 304 SER A 311 1 8 HELIX 15 AB6 GLY A 328 GLY A 335 1 8 HELIX 16 AB7 SER A 348 VAL A 360 1 13 HELIX 17 AB8 ASN A 364 TYR A 375 1 12 HELIX 18 AB9 ASN A 383 VAL A 400 1 18 HELIX 19 AC1 VAL A 400 LYS A 413 1 14 HELIX 20 AC2 PRO A 433 GLY A 437 5 5 HELIX 21 AC3 GLU A 443 PHE A 448 1 6 HELIX 22 AC4 VAL A 453 ASN A 457 5 5 HELIX 23 AC5 THR A 459 GLY A 480 1 22 HELIX 24 AC6 ARG A 517 GLN A 526 1 10 HELIX 25 AC7 GLN A 526 THR A 535 1 10 SHEET 1 AA1 3 LEU A 7 THR A 10 0 SHEET 2 AA1 3 GLY A 13 MET A 16 -1 O VAL A 15 N VAL A 8 SHEET 3 AA1 3 VAL A 57 ASN A 59 1 O TRP A 58 N MET A 16 SHEET 1 AA211 THR A 18 VAL A 22 0 SHEET 2 AA211 SER A 25 PRO A 34 -1 O ILE A 27 N VAL A 20 SHEET 3 AA211 TYR A 96 VAL A 101 -1 O VAL A 101 N SER A 28 SHEET 4 AA211 VAL A 142 SER A 145 -1 O LEU A 143 N TRP A 100 SHEET 5 AA211 THR A 109 ILE A 115 1 N TRP A 114 O VAL A 144 SHEET 6 AA211 GLY A 189 GLU A 199 1 O ASP A 190 N THR A 109 SHEET 7 AA211 ARG A 221 GLN A 225 1 O ILE A 223 N ILE A 196 SHEET 8 AA211 GLN A 318 ASN A 324 1 O LEU A 320 N ALA A 222 SHEET 9 AA211 GLY A 417 PHE A 423 1 O PHE A 423 N VAL A 323 SHEET 10 AA211 LYS A 501 LEU A 505 1 O ILE A 503 N PHE A 422 SHEET 11 AA211 VAL A 512 GLN A 514 -1 O HIS A 513 N PHE A 502 SHEET 1 AA3 2 VAL A 236 SER A 237 0 SHEET 2 AA3 2 VAL A 295 ILE A 296 1 O ILE A 296 N VAL A 236 SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.03 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.03 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.04 LINK ND2 ASN A 59 C1 NAG A 601 1555 1555 1.47 LINK ND2 ASN A 416 C1 NAG A 602 1555 1555 1.45 CISPEP 1 SER A 103 PRO A 104 0 0.12 CRYST1 111.040 111.040 137.227 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009006 0.005199 0.000000 0.00000 SCALE2 0.000000 0.010399 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007287 0.00000